Since the initial reports, in the early 1960s, of Transfusion-Associated Graft-versus-Host Disease (TA-GVHD) in infants with congenital immunodeficiency and individuals with various haematological malignancies, our knowledge of this rare but uniformly fatal consequence of transfusion has improved. Today, it is possible to define with greater certainty patients who are most at risk; the blood components capable of causing TA-GVHD; and the methods for preventing TA-GVHD. In the absence of effective treatment for TA-GVHD, attention is currently focused on potential preventative measures, in particular using u.v.- or gamma-irradiated blood components. This overview deals with some general aspects of the current concepts and future trends in treatment of TA-GVHD.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0955-3886(95)00000-nDOI Listing

Publication Analysis

Top Keywords

transfusion-associated graft-versus-host
8
graft-versus-host disease
8
current concepts
8
concepts future
8
future trends
8
blood components
8
treatment ta-gvhd
8
ta-gvhd
5
disease current
4
trends initial
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!